French pharmaceutical company Sanofi had asked suitors to revise their proposals for the Opella business, Bloomberg News reported earlier this week. The new bids may exclude parts of the Gold Bond ...

GSK Plc, Sanofi, and CSL Ltd. secured $72 million from the US government to ramp up production of bird flu vaccines as a nationwide outbreak among livestock and poultry has led to several human ...

As part of the agreement, GSK, Sanofi, and CSL will produce extra bulk vaccine components tailored to the circulating strains of avian influenza. Also Read: Medicare Drug Price Negotiation Program ...

The latest award from the Administration for Strategic Preparedness and Response of $72 million includes $37.9 million for CSL, $23.4 million for Sanofi, and $10.5 million for GSK. Read Next: ...

assuming no additional business development transactions. In September, Sanofi agreed to make a $27 million strategic investment in Ventyx Biosciences Inc. The company also agreed to grant Sanofi ...

Enjaymo, however, would move to yet another owner in 2018, when Sanofi bought Bioverativ for $11 billion. Sanofi has turned to dealmaking several times since to further build out its rare disease ...

Under the deal announced Friday, the Italian pharma will make an upfront payment of $825 million to Sanofi for global rights to a biologic for the treatment of cold agglutinin disease, with milestone ...

Compare top options and learn how to get a business credit card if your personal FICO score is below 630. Many, or all, of the products featured on this page are from our advertising partners who ...

Business credit cards can help business owners streamline expenses, earn rewards and finance larger purchases. However, opening a new credit card can sometimes be easier said than done.

Please view our full advertiser disclosure policy. The information for the American Express® Business Gold Card has been collected independently by Blueprint. The card details on this page have ...

Sanofi in 2024 changed its travel policy to remove a requirement for manager approval of traveler expense reports, as it instead has deployed an AI-based service to audit them. The company's 2023 ...

The Food and Drug Administration on Friday approved Regeneron Pharmaceuticals and Sanofi’s inflammatory disease drug Dupixent for a common lung condition. The decision could significantly expand use ...